These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 23335510)

  • 1. Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.
    Heatley SL; Pietra G; Lin J; Widjaja JML; Harpur CM; Lester S; Rossjohn J; Szer J; Schwarer A; Bradstock K; Bardy PG; Mingari MC; Moretta L; Sullivan LC; Brooks AG
    J Biol Chem; 2013 Mar; 288(12):8679-8690. PubMed ID: 23335510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis.
    Vietzen H; Rückert T; Hartenberger S; Honsig C; Jaksch P; Geleff S; Hammer Q; Romagnani C; Segura-Wang M; Puchhammer-Stöckl E
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity.
    Cerboni C; Mousavi-Jazi M; Wakiguchi H; Carbone E; Kärre K; Söderström K
    Eur J Immunol; 2001 Oct; 31(10):2926-35. PubMed ID: 11592068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
    Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL
    EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.
    Petrie EJ; Clements CS; Lin J; Sullivan LC; Johnson D; Huyton T; Heroux A; Hoare HL; Beddoe T; Reid HH; Wilce MC; Brooks AG; Rossjohn J
    J Exp Med; 2008 Mar; 205(3):725-35. PubMed ID: 18332182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.
    Llano M; Lee N; Navarro F; García P; Albar JP; Geraghty DE; López-Botet M
    Eur J Immunol; 1998 Sep; 28(9):2854-63. PubMed ID: 9754572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
    Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE
    J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.
    Borrego F; Ulbrecht M; Weiss EH; Coligan JE; Brooks AG
    J Exp Med; 1998 Mar; 187(5):813-8. PubMed ID: 9480992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Presence of HLA-E-Restricted, CMV-Specific CD8+ T Cells in the Blood of Lung Transplant Recipients Correlates with Chronic Allograft Rejection.
    Sullivan LC; Westall GP; Widjaja JM; Mifsud NA; Nguyen TH; Meehan AC; Kotsimbos TC; Brooks AG
    PLoS One; 2015; 10(8):e0135972. PubMed ID: 26302084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis.
    Ulbrecht M; Martinozzi S; Grzeschik M; Hengel H; Ellwart JW; Pla M; Weiss EH
    J Immunol; 2000 May; 164(10):5019-22. PubMed ID: 10799855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells.
    Pietra G; Romagnani C; Moretta L; Mingari MC
    Curr Pharm Des; 2009; 15(28):3336-44. PubMed ID: 19860683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.
    Gumá M; Budt M; Sáez A; Brckalo T; Hengel H; Angulo A; López-Botet M
    Blood; 2006 May; 107(9):3624-31. PubMed ID: 16384928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
    Michaëlsson J; Teixeira de Matos C; Achour A; Lanier LL; Kärre K; Söderström K
    J Exp Med; 2002 Dec; 196(11):1403-14. PubMed ID: 12461076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.
    Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J
    J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2.
    Miller JD; Weber DA; Ibegbu C; Pohl J; Altman JD; Jensen PE
    J Immunol; 2003 Aug; 171(3):1369-75. PubMed ID: 12874227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leukocyte antigen E in human cytomegalovirus infection: friend or foe?
    Gong F; Song S; Lv G; Pan Y; Zhang D; Jiang H
    Acta Biochim Biophys Sin (Shanghai); 2012 Jul; 44(7):551-4. PubMed ID: 22576308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.
    Lee N; Llano M; Carretero M; Ishitani A; Navarro F; López-Botet M; Geraghty DE
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5199-204. PubMed ID: 9560253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells.
    Vance RE; Jamieson AM; Raulet DH
    J Exp Med; 1999 Dec; 190(12):1801-12. PubMed ID: 10601355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.